Alice GAUDIN

Alice Gaudin has a diverse work experience spanning various roles and companies. Alice is currently the Head of Pharmaceutical Sciences at Advanced BioDesign since March 2022. Prior to this role, they worked as a Project Manager at the same company from May 2019 to March 2022. Alice also worked as a Senior Scientist - Novel Drug Delivery Formulations at Ipsen from February 2017 to August 2018. Before that, they were a Post-doctorate at Yale University - Department of Biomedical Engineering from February 2015 to January 2017. Alice completed their Doctorate at Université Paris-Sud from October 2011 to November 2014, where they focused on the development, characterization, and evaluation of lipid nanoparticles for the treatment of cerebral ischemia and spinal cord injuries. Alice has also gained experience as an Intern Engineer at companies including Bracco, Institut Langevin, Laboratoire de Neurobiologie UMR7637, and Guerbet. Their roles during these internships involved various tasks such as technique development, validation, administration, and engineering.

Alice Gaudin started their education in 2002 at Lycée Louis-le-Grand, where they obtained a Baccalauréat degree with a focus on scientific studies, with a specialization in physics and chemistry, in 2005. Alice then attended ESPCI Paris - PSL from 2007 to 2011, earning a Diplôme d'ingénieur degree in physics, chemistry, and biology. Additionally, they completed a Mastère spécialisé de BioIngénierie at ESPCI Paris - PSL from 2010 to 2011. Throughout their education, Alice focused on various subjects including physiology, neuroscience, medicinal chemistry, immunology, endocrinology, and biostatistics.